E. Pajetta

Intranasal and intramuscular human calcitonin in female osteoporosis and in Paget’s disease of bones: a pilot study

A. Pontiroli, V. Manganelli, G. Pozza, 1991, Journal of endocrinological investigation.

Analgesic effect of intranasal and intramuscular salmon calcitonin in post-menopausal osteoporosis: A double-blind, double-placebo study

A. Pontiroli, G. Pozza, L. Scaglia, 1994, Aging.

Nasal administration of glucagon and human calcitonin to healthy subjects: a comparison of powders and spray solutions and of different enhancing agents

A. Pontiroli, G. Pozza, M. Alberetto, 2004, European Journal of Clinical Pharmacology.

Metabolic Effects of Intranasally Administered Insulin and Glucagon in Man

A. Pontiroli, G. Pozza, M. Alberetto, 1986 .

Intranasal Glucagon as Remedy for Hypoglycemia: Studies in Healthy Subjects and Type I Diabetic Patients

A. Pontiroli, G. Pozza, M. Alberetto, 1989, Diabetes Care.

Human Calcitonin Administered by the Nasal Route: Bioavailability of Different Formulations and Efficacy in Post-Menopausal Osteoporosis

A. Pontiroli, V. Manganelli, G. Pozza, 1986 .

Phänotypische Klassifikation akuter Leukosen durch funktionelle Parameter: Implikationen für Subklassifikation und Prognose

F. Resch, E. Neumann, K. Lechner, 1982 .